Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESOMEPRAZOLE Cause Hyperkalaemia? 300 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 300 reports of Hyperkalaemia have been filed in association with ESOMEPRAZOLE (Esomeprazole Magnesium). This represents 0.4% of all adverse event reports for ESOMEPRAZOLE.

300
Reports of Hyperkalaemia with ESOMEPRAZOLE
0.4%
of all ESOMEPRAZOLE reports
77
Deaths
170
Hospitalizations

How Dangerous Is Hyperkalaemia From ESOMEPRAZOLE?

Of the 300 reports, 77 (25.7%) resulted in death, 170 (56.7%) required hospitalization, and 34 (11.3%) were considered life-threatening.

Is Hyperkalaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE. However, 300 reports have been filed with the FAERS database.

What Other Side Effects Does ESOMEPRAZOLE Cause?

Chronic kidney disease (35,281) Acute kidney injury (18,678) Renal failure (14,633) End stage renal disease (10,231) Renal injury (9,440) Gastrooesophageal reflux disease (4,746) Drug ineffective (4,420) Tubulointerstitial nephritis (4,024) Off label use (3,180) Pain (2,898)

What Other Drugs Cause Hyperkalaemia?

METFORMIN (2,565) SPIRONOLACTONE (2,518) FUROSEMIDE (2,035) RAMIPRIL (1,383) SACUBITRIL\VALSARTAN (1,192) SULFAMETHOXAZOLE\TRIMETHOPRIM (1,036) LISINOPRIL (948) POTASSIUM (944) BISOPROLOL (850) TACROLIMUS (713)

Which ESOMEPRAZOLE Alternatives Have Lower Hyperkalaemia Risk?

ESOMEPRAZOLE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE ESOMEPRAZOLE vs ESOMEPRAZOLE\NAPROXEN ESOMEPRAZOLE vs ESTAZOLAM ESOMEPRAZOLE vs ESTRADIOL ESOMEPRAZOLE vs ESTRADIOL CYPIONATE

Related Pages

ESOMEPRAZOLE Full Profile All Hyperkalaemia Reports All Drugs Causing Hyperkalaemia ESOMEPRAZOLE Demographics